Recent Updates
Recently added Catalysts
AMGN Positive Sentiment

AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE

Key Takeaway: Amgen will present at the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026. Key executives, including CFO Peter Griffith and SVP Jasper van Grunsven, will participate in a fireside chat. The event will be available via webcast for media, investors, and the public, with an archive accessible for 90 days post-event.
Price reaction · baseline $367.6 (2026-03-05 close) · hit after-hours · clean, no other AMGN news in the window
day 0 close
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen is actively engaging with investors at a major healthcare conference.
  • The participation of high-level executives indicates strong leadership and communication.
  • The webcast allows broad access to information about Amgen's developments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif.,March 5, 2026/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference at 9:20 a.m. ET on Wednesday, March 11, 2026. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jasper van Grunsven, senior vice president of rare disease at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website,www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has beenconsistently recognizedfor innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visitAmgen.comand follow Amgen onX,LinkedIn,Instagram,YouTube,Facebook,TikTokandThreads.

Frequently Asked Questions

When will Amgen present at the conference?

Amgen will present at the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026.

Who will represent Amgen at the conference?

Peter Griffith and Jasper van Grunsven will represent Amgen during the fireside chat.

How can I access the conference webcast?

The webcast will be available on Amgen's website and can be accessed by the public.

Will the webcast be available after the event?

Yes, the webcast will be archived and available for replay for at least 90 days.

Last updated: Mar 5, 2026